Tiantian, a 7-year-old boy who was only 1 year old in 2017, was given a hematology test at the local children's hospital due to persistent fever. The results showed hemoglobin 50 g/L, and he was genetically diagnosed asβ-thalassemia major, with HBB double mutation in genotype. Tiantian had very obvious symptoms of anemia when he was diagnosed, and red cells transfusions were needed. As Tiantian grew older, the pressure of blood use was also increasing, and the amount of blood transfusion increased from 2 units/time to 3 units/time, almost every other month to be transfused to maintain the hemoglobin level at about 90 g/L.

In 2022, Tiantian came to GHG medical center with his parents. With the efforts of the doctor team, Tiantian received a TDH transplant. Today, Tiantian has completely discontinued the drug and returned to a happy childhood life.

"We know that the GHG medial team's thalassemia transplant success rate is 97%, and we chose to trust the team's decades of experience in thalassemia transplant compared to the possible risks. He went to the hospital for blood transfusion and iron chelation every month and was hospitalized for at least 2 days. Since injections were too many with vasoconstriction, the injection might succeed after 2-3 times of trying, we felt very distressed as his parents. Thanks to the doctors and nurses. It is they that make Tiantian now have a normal, and happy childhood like other children."